Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 8/2019

01-07-2019 | Lung Cancer | Image of the Month

FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis

Authors: Frederik L. Giesel, Claus Peter Heussel, Thomas Lindner, Manuel Röhrich, Hendrik Rathke, Hans-Ulrich Kauczor, Jürgen Debus, Uwe Haberkorn, Clemens Kratochwil

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 8/2019

Login to get access

Excerpt

FDG-PET/CT is the current mainstay of lung cancer staging and presents favorable sensitivity and specificity in comparison to morphological diagnostic means especially for mediastinal lymph-node assessment. However, high physiological uptake in the brain requires additional cerebral magnetic resonance imaging to complete M-staging. Although not a major limitation, the dependency of FDG on blood sugar and the need of preparatory fasting and to recline during the 1-h uptake phase is inconvenient, hampering smooth patient workflow [1]. …
Literature
Metadata
Title
FAPI-PET/CT improves staging in a lung cancer patient with cerebral metastasis
Authors
Frederik L. Giesel
Claus Peter Heussel
Thomas Lindner
Manuel Röhrich
Hendrik Rathke
Hans-Ulrich Kauczor
Jürgen Debus
Uwe Haberkorn
Clemens Kratochwil
Publication date
01-07-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 8/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04346-z

Other articles of this Issue 8/2019

European Journal of Nuclear Medicine and Molecular Imaging 8/2019 Go to the issue